These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24402141)

  • 21. Neonatal NMDA receptor antagonist treatments have no effects on prepulse inhibition of postnatal day 25 Sprague-Dawley rats.
    Boctor SY; Ferguson SA
    Neurotoxicology; 2009 Jan; 30(1):151-4. PubMed ID: 19038286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7.
    Boctor SY; Ferguson SA
    Neurotoxicology; 2010 Jan; 31(1):42-54. PubMed ID: 19853622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal PCP is more potent than ketamine at modifying preweaning behaviors of Sprague-Dawley rats.
    Boctor SY; Wang C; Ferguson SA
    Toxicol Sci; 2008 Nov; 106(1):172-9. PubMed ID: 18667523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
    Metaxas A; Willems R; Kooijman EJ; Renjaän VA; Klein PJ; Windhorst AD; Donck LV; Leysen JE; Berckel BN
    J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
    Watson DJG; King MV; Gyertyán I; Kiss B; Adham N; Fone KCF
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):208-224. PubMed ID: 26723167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups.
    Anastasio NC; Johnson KM
    Pharmacol Biochem Behav; 2008 Oct; 90(4):569-77. PubMed ID: 18544461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
    Linn GS; Negi SS; Gerum SV; Javitt DC
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phencyclidine increased while isolation rearing did not affect progressive ratio responding in rats: Investigating potential models of amotivation in schizophrenia.
    Amitai N; Powell SB; Young JW
    Behav Brain Res; 2019 May; 364():413-422. PubMed ID: 29175446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
    Schwabe K; Brosda J; Wegener N; Koch M
    Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia.
    Wang C; McInnis J; Ross-Sanchez M; Shinnick-Gallagher P; Wiley JL; Johnson KM
    Neuroscience; 2001; 107(4):535-50. PubMed ID: 11720778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats.
    Maple AM; Call T; Kimmel PC; Hammer RP
    J Pharmacol Exp Ther; 2017 Apr; 361(1):109-114. PubMed ID: 28167638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.
    Thomson S; Dyck B; Daya R; Ho J; Bernardo A; Tian Y; Mishra RK
    Synapse; 2019 May; 73(5):e22084. PubMed ID: 30582667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia.
    Pyndt Jørgensen B; Krych L; Pedersen TB; Plath N; Redrobe JP; Hansen AK; Nielsen DS; Pedersen CS; Larsen C; Sørensen DB
    Physiol Behav; 2015 Mar; 141():32-9. PubMed ID: 25545766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine.
    Matsuura A; Fujita Y; Iyo M; Hashimoto K
    Acta Neuropsychiatr; 2015 Jun; 27(3):159-67. PubMed ID: 25648314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
    Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia.
    Grayson B; Adamson L; Harte M; Leger M; Marsh S; Piercy C; Neill JC
    Behav Brain Res; 2014 Jun; 266():188-92. PubMed ID: 24632009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.